Halberd Corporation
HALB
Rank in Stocks
#32762
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies... Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.
Share Price
$0.0016
Last synced: 2026-11-18
Market Cap
$1.13M
Change (1 day)
-2.44%
Change (1 year)
15.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Halberd Corporation (HALB)
Category
Healthcare
P/S ratio for Halberd Corporation (HALB)
P/S ratio as of November 2026 TTM: 0.00
According to Halberd Corporation's latest financial reports and stock price, its current price-to-sales ratio (TTM) is 0.00. At the end of 2025 the company had a P/S ratio of 0.00.
P/S ratio history for Halberd Corporation from 2008 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | -100.00% |
| 2024 | 4.07K | 113.10% |
| 2023 | 1.91K | 135.64% |
| 2022 | 811.38 | -72.88% |
| 2021 | 2.99K | 0.00% |
| 2020 | 0.00 | 0.00% |
| 2019 | 0.00 | 0.00% |
| 2018 | 0.00 | -100.00% |
| 2017 | 2.26 | 493.14% |
| 2016 | 0.38 | -78.61% |
| 2015 | 1.78 | -80.42% |
| 2014 | 9.09 | 76.82% |
| 2013 | 5.14 | -64.01% |
| 2012 | 14.29 | -45.77% |
| 2011 | 26.34 | 567.37% |
| 2010 | 3.95 | -99.74% |
| 2009 | 1.50K | 427.26% |
| 2008 | 285.13 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 10.51 | - |
US
|
|
| 35.79 | - |
US
|
|
| 4.19 | - |
AU
|
|
| 6.63 | - |
BE
|
|
| 13.60 | - |
NL
|
Questions about Halberd Corporation's P/S ratio
What was Halberd Corporation's P/S ratio in 2025?
In 2025, Halberd Corporation's P/S ratio was 0.00, compared with 4.07K in 2024.
How has Halberd Corporation's P/S ratio changed since 2020?
From 2020 to 2025, Halberd Corporation's P/S ratio was highest in 2024 (4.07K) and lowest in 2025 (0.00).
How does Halberd Corporation's P/S ratio compare with similar companies?
Halberd Corporation's P/S ratio (0.00) is lower than that of all 5 similar companies listed above. The highest among them is Moderna, Inc., with 35.79.